Cargando…
Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures
Simultaneous administration of parenteral nutrition (PN) admixtures with intravenous antibiotics is a common clinical problem. Coadministration of drugs incompatible with PN admixture may affect its stability, especially in the context of lipid droplet size, which is a crucial parameter for patient...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926682/ https://www.ncbi.nlm.nih.gov/pubmed/33671502 http://dx.doi.org/10.3390/antibiotics10020217 |
_version_ | 1783659517550002176 |
---|---|
author | Gostyńska, Aleksandra Piwowarczyk, Ludwika Nadolna, Malwina Jelińska, Anna Dettlaff, Katarzyna Ogrodowczyk, Magdalena Popielarz-Brzezińska, Maria Stawny, Maciej |
author_facet | Gostyńska, Aleksandra Piwowarczyk, Ludwika Nadolna, Malwina Jelińska, Anna Dettlaff, Katarzyna Ogrodowczyk, Magdalena Popielarz-Brzezińska, Maria Stawny, Maciej |
author_sort | Gostyńska, Aleksandra |
collection | PubMed |
description | Simultaneous administration of parenteral nutrition (PN) admixtures with intravenous antibiotics is a common clinical problem. Coadministration of drugs incompatible with PN admixture may affect its stability, especially in the context of lipid droplet size, which is a crucial parameter for patient safety. In the present study, we investigate the in vitro compatibility of meropenem (Meropenem 1000, MPM) with five commercial PN admixtures used worldwide: Kabiven, Olimel N9E, Nutriflex Lipid Special, Nutriflex Omega Special, and SmofKabiven. The appropriate volumetric ratios, reflecting their clinical practice ratios, were used to prepare the MPM–PN admixture samples. Physicochemical properties of MPM–PN admixtures samples were determined upon preparation and after four hours of storage. The pH changes for all MPM–PN admixtures samples did not exceed the assumed level of acceptability and ranged from 6.41 to 7.42. After four hours of storage, the osmolarity changes were ±3%, except MPM–Olimel N9E samples, for which differences from 7% to 11% were observed. The adopted level of acceptability of changes in zeta potential after four hours of storage (±3 mV) was met for MPM–Kabiven, MPM–Nutriflex Lipid Special, and MPM–Nutriflex Omega Special. The mean droplet diameter for all samples was below 500 nm. However, only in the case of Nutriflex Lipid Special and Nutriflex Omega Special, the addition of MPM did not cause the formation of the second fraction of lipid droplets. The coadministration of MPM via Y-site with Kabiven, Olimel N9E, and Smofkabiven should be avoided due to osmolarity fluctuations (MPM–Olimel), significant differences in zeta potential (MPM–Olimel, MPM–Smofkabiven), and the presence of the second fraction of lipid droplets >1000 nm (MPM–Kabiven, MPM–Olimel, and MPM–Smofkabiven). The assumed acceptance criteria for MPM compatibility of MPM with PN admixtures were met only for Nutriflex Lipid Special and Nutriflex Omega Special in 1:1, 2:1, and 4:1 volume ratios. |
format | Online Article Text |
id | pubmed-7926682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79266822021-03-04 Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures Gostyńska, Aleksandra Piwowarczyk, Ludwika Nadolna, Malwina Jelińska, Anna Dettlaff, Katarzyna Ogrodowczyk, Magdalena Popielarz-Brzezińska, Maria Stawny, Maciej Antibiotics (Basel) Article Simultaneous administration of parenteral nutrition (PN) admixtures with intravenous antibiotics is a common clinical problem. Coadministration of drugs incompatible with PN admixture may affect its stability, especially in the context of lipid droplet size, which is a crucial parameter for patient safety. In the present study, we investigate the in vitro compatibility of meropenem (Meropenem 1000, MPM) with five commercial PN admixtures used worldwide: Kabiven, Olimel N9E, Nutriflex Lipid Special, Nutriflex Omega Special, and SmofKabiven. The appropriate volumetric ratios, reflecting their clinical practice ratios, were used to prepare the MPM–PN admixture samples. Physicochemical properties of MPM–PN admixtures samples were determined upon preparation and after four hours of storage. The pH changes for all MPM–PN admixtures samples did not exceed the assumed level of acceptability and ranged from 6.41 to 7.42. After four hours of storage, the osmolarity changes were ±3%, except MPM–Olimel N9E samples, for which differences from 7% to 11% were observed. The adopted level of acceptability of changes in zeta potential after four hours of storage (±3 mV) was met for MPM–Kabiven, MPM–Nutriflex Lipid Special, and MPM–Nutriflex Omega Special. The mean droplet diameter for all samples was below 500 nm. However, only in the case of Nutriflex Lipid Special and Nutriflex Omega Special, the addition of MPM did not cause the formation of the second fraction of lipid droplets. The coadministration of MPM via Y-site with Kabiven, Olimel N9E, and Smofkabiven should be avoided due to osmolarity fluctuations (MPM–Olimel), significant differences in zeta potential (MPM–Olimel, MPM–Smofkabiven), and the presence of the second fraction of lipid droplets >1000 nm (MPM–Kabiven, MPM–Olimel, and MPM–Smofkabiven). The assumed acceptance criteria for MPM compatibility of MPM with PN admixtures were met only for Nutriflex Lipid Special and Nutriflex Omega Special in 1:1, 2:1, and 4:1 volume ratios. MDPI 2021-02-22 /pmc/articles/PMC7926682/ /pubmed/33671502 http://dx.doi.org/10.3390/antibiotics10020217 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gostyńska, Aleksandra Piwowarczyk, Ludwika Nadolna, Malwina Jelińska, Anna Dettlaff, Katarzyna Ogrodowczyk, Magdalena Popielarz-Brzezińska, Maria Stawny, Maciej Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures |
title | Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures |
title_full | Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures |
title_fullStr | Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures |
title_full_unstemmed | Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures |
title_short | Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures |
title_sort | toward safe pharmacotherapy: the interplay between meropenem and parenteral nutrition admixtures |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926682/ https://www.ncbi.nlm.nih.gov/pubmed/33671502 http://dx.doi.org/10.3390/antibiotics10020217 |
work_keys_str_mv | AT gostynskaaleksandra towardsafepharmacotherapytheinterplaybetweenmeropenemandparenteralnutritionadmixtures AT piwowarczykludwika towardsafepharmacotherapytheinterplaybetweenmeropenemandparenteralnutritionadmixtures AT nadolnamalwina towardsafepharmacotherapytheinterplaybetweenmeropenemandparenteralnutritionadmixtures AT jelinskaanna towardsafepharmacotherapytheinterplaybetweenmeropenemandparenteralnutritionadmixtures AT dettlaffkatarzyna towardsafepharmacotherapytheinterplaybetweenmeropenemandparenteralnutritionadmixtures AT ogrodowczykmagdalena towardsafepharmacotherapytheinterplaybetweenmeropenemandparenteralnutritionadmixtures AT popielarzbrzezinskamaria towardsafepharmacotherapytheinterplaybetweenmeropenemandparenteralnutritionadmixtures AT stawnymaciej towardsafepharmacotherapytheinterplaybetweenmeropenemandparenteralnutritionadmixtures |